Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition

The discovery of potent, MCH-R1 antagonists with minimized hERG inhibition through SAR analysis and physicochemical parameters modulation is herein described.